Tuesday 29th June 2021, 10 a.m. EDT | 4 p.m. CEST
Biopharma Dealmaking in 2021: Trends and Transformation
After a turbulent year of remote dealmaking under COVID-19 restrictions, the biopharma sector has kicked off 2021 with renewed vigor. Billion dollar deals abound, merger and acquisition activities are accelerating, and deals are being made earlier and faster than ever.
In this exclusive webinar, Chris Dokomajilar, founder and CEO of DealForma, and Gilles Toulemonde, CEO of Inova, will present the trends they are tracking and speak to the ongoing digital transformation of biopharma dealmaking. They'll discuss what deals have been done so far in 2021, identify some of the difficulties that pharma companies are experiencing in attracting biotechs, and explain what to watch in deal making and partnering best practices for the second half of 2021.